《Lancet,6月3日,The impact of ethnicity on clinical outcomes in COVID-19: A systematic review》

  • 来源专题:COVID-19科研动态监测
  • 编译者: zhangmin
  • 发布时间:2020-06-04
  • The impact of ethnicity on clinical outcomes in COVID-19: A systematic review

    Daniel Pan 1

    Shirley Sze 1

    Jatinder S. Minhas

    Mansoor N. Bangash

    Nilesh Pareek

    Pip Divall

    et al.

    Open AccessPublished:June 03, 2020DOI:https://doi.org/10.1016/j.eclinm.2020.100404

    Abstract

    Background

    The relationship between ethnicity and COVID-19 is uncertain. We performed a systematic review to assess whether ethnicity has been reported in patients with COVID-19 and its relation to clinical outcomes.

    Methods

    We searched EMBASE, MEDLINE, Cochrane Library and PROSPERO for English-language citations on ethnicity and COVID-19 (1st December 2019-15th May 2020). We also reviewed: COVID-19 articles in NEJM, Lancet, BMJ, JAMA, clinical trial protocols, grey literature, surveillance data and preprint articles on COVID-19 in MedRxiv to evaluate if the association between ethnicity and clinical outcomes were reported and what they showed. PROSPERO:180654.

  • 原文来源:https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(20)30148-6/fulltext
相关报告
  • 《Lancet,6月26日,COVID-19 in 7780 pediatric patients: A systematic review》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-06-27
    • COVID-19 in 7780 pediatric patients: A systematic review Ansel Hoang Kevin Chorath † Axel Moreira Mary Evans Finn Burmeister-Morton Fiona Burmeister et al. Open AccessPublished:June 26, 2020DOI:https://doi.org/10.1016/j.eclinm.2020.100433 Abstract Background Studies summarizing the clinical picture of COVID-19 in children are lacking. This review characterizes clinical symptoms, laboratory, and imaging findings, as well as therapies provided to confirmed pediatric cases of COVID-19. Methods Adhering to PRISMA guidelines, we searched four medical databases (PubMed, LitCovid, Scopus, WHO COVID-19 database) between December 1, 2019 to May 14, 2020 using the keywords “novel coronavirus”, “COVID-19” or “SARS-CoV-2”. We included published or in press peer-reviewed cross-sectional, case series, and case reports providing clinical signs, imaging findings, and/or laboratory results of pediatric patients who were positive for COVID-19. Risk of bias was appraised through the quality assessment tool published by the National Institutes of Health. PROSPERO registration # CRD42020182261.
  • 《Lancet,3月24日,Early in the epidemic: impact of preprints on global discourse about COVID-19 transmissibility》

    • 来源专题:COVID-19科研动态监测
    • 编译者:xuwenwhlib
    • 发布时间:2020-03-25
    • Early in the epidemic: impact of preprints on global discourse about COVID-19 transmissibility Maimuna S Majumder Kenneth D Mandl Open AccessPublished:March 24, 2020DOI:https://doi.org/10.1016/S2214-109X(20)30113-3 Since it was first reported by WHO in Jan 5, 2020, over 80?000 cases of a novel coronavirus disease (COVID-19) have been diagnosed in China, with exportation events to nearly 90 countries, as of March 6, 2020.1 Given the novelty of the causative pathogen (named SARS-CoV-2), scientists have rushed to fill epidemiological, virological, and clinical knowledge gaps—resulting in over 50 new studies about the virus between January 10 and January 30 alone.2 However, in an era where the immediacy of information has become an expectation of decision makers and the general public alike, many of these studies have been shared first in the form of preprint papers—before peer review.